Galenicum Health Peru and Chile launch a new business unit focused on pain relief with dexketoprofen and celecoxib

January 26, 2018

Galenicum Health Peru and Galenicum Health Chile are launching this year a new business unit focused on products for pain relief. This are dexketoprofen for Peru and celecoxib for Chile. Both are nonsteroidal anti-inflammatory drugs, indicated to reduce inflammation and relieve pain.

These products suit perfectly our growing portfolio in the cardiovascular, neuroscience and oncology therapeutic areas.

We hope to achieve a great reception in both countries and help patients and doctors to obtain a new safe and effective therapeutic option.